Headache is one of the most common neurological complaints encountered in clinical practice. Although most headaches are benign, clinicians must distinguish primary headache disorders from secondary headaches, which may signal potentially serious underlying pathology. A careful history, focused physical and neurological examination, and recognition of red-flag findings are essential for determining when additional diagnostic evaluation is necessary.
Primary headaches occur independently and are not caused by another underlying disease or structural abnormality. Their pathophysiology is often multifactorial and may involve genetic susceptibility, neurovascular mechanisms, and environmental or lifestyle triggers. Common primary headache disorders include tension-type headache, migraine, and cluster headache.
In contrast, secondary headaches occur as a manifestation of another condition. Potential causes include intracranial hemorrhage, tumors, central nervous system (CNS) infections, vascular abnormalities, severe hypertension, metabolic disturbances, and systemic infections. Unlike most primary headaches, secondary headaches generally improve only when the underlying cause is identified and appropriately treated.
The clinical history and neurological examination are critical in differentiating primary from secondary headaches. Patients with a typical primary headache disorder generally have a normal neurological examination. Symptoms such as photophobia, phonophobia, nausea, or transient neurological manifestations associated with migraine aura may occur without indicating structural disease.
Secondary headaches, however, are more likely to be accompanied by abnormal neurological or systemic findings. For example, headache associated with increased intracranial pressure may be more prominent upon awakening and may occur with vomiting, papilledema, or focal neurological abnormalities.
A useful framework for recognizing concerning features (red flags) is the SNOOP mnemonic:
The presence of these findings does not automatically establish a secondary diagnosis, but it should lower the threshold for additional evaluation.
When concerning clinical features are present, neuroimaging may be necessary.
Computed tomography (CT) is rapid and widely available, making it particularly useful in emergency settings. Noncontrast CT is commonly used when acute intracranial hemorrhage is suspected and is also useful for identifying certain bony abnormalities. However, CT exposes the patient to ionizing radiation and provides less soft-tissue detail than MRI.
Magnetic resonance imaging (MRI) provides superior visualization of soft tissues and is particularly valuable for subtle intracranial lesions and posterior fossa pathology. MRI does not use ionizing radiation but generally takes longer, costs more, and may not be appropriate for patients with certain non-MRI-compatible implants or devices.
The choice between CT and MRI should therefore be guided by the suspected diagnosis, urgency of the presentation, and individual patient factors rather than simply by the presence of headache.
Tension-type headache typically presents as bilateral, pressing or tightening pain that patients may describe as a band around the head. Pain is usually mild to moderate and is not typically worsened by routine physical activity. Episodes can last from approximately 30 minutes to several days.
Acute treatment commonly includes acetaminophen or NSAIDs when clinically appropriate. For patients with frequent or chronic tension-type headaches, preventive treatment such as amitriptyline may be considered.
Migraine typically produces moderate-to-severe headache, often with a unilateral and pulsating quality. Routine activity may aggravate the pain, and patients frequently experience nausea, vomiting, photophobia, or phonophobia. Untreated migraine attacks generally last 4–72 hours.
Some patients experience migraine with aura, characterized by reversible neurological symptoms—most commonly visual, sensory, or language disturbances—that usually develop gradually and resolve.
Acute migraine treatment may include NSAIDs, acetaminophen, triptans, gepants, or lasmiditan, depending on headache severity, patient characteristics, contraindications, and previous treatment response. Preventive options include selected beta-blockers, topiramate, certain antidepressants (TCAs such as nortripytline and amitriptyline, as well as SNRIs, including venlafaxine), anti-epileptic drugs (divalproex sodium, sodium valproate, and topiramate) and medications targeting the calcitonin gene-related peptide (CGRP) pathway (such as fremanezumab, erenumab and galcanezumab).
Cluster headache is characterized by severe or excruciating strictly unilateral pain, typically involving the orbital, supraorbital, or temporal region. Individual attacks generally last 15–180 minutes and may occur repeatedly during a cluster period.
Unlike migraine, patients with cluster headache commonly develop prominent ipsilateral autonomic symptoms, including lacrimation, conjunctival injection, rhinorrhea or nasal congestion, eyelid edema, ptosis, or miosis. Patients may also appear restless or agitated during attacks.
Acute treatment includes 100% oxygen delivered appropriately and rapidly acting triptans, particularly subcutaneous or intranasal formulations. Verapamil is commonly used for prevention, while corticosteroids may sometimes be used as transitional therapy while preventive treatment takes effect.
The most important question when evaluating a patient with headache is not simply “What type of headache is this?” but also “Is there evidence that this headache represents something dangerous?”
A patient with years of stereotypical migraines, a normal neurological examination, and no meaningful change in headache pattern may not require immediate neuroimaging. Conversely, a patient presenting with a first-ever thunderclap headache, new focal neurological deficits, altered mental status, papilledema, fever with meningeal signs, or a substantially changed headache pattern requires prompt investigation for secondary causes.
Another important consideration is medication-overuse headache. Frequent use of acute headache medications can paradoxically increase headache frequency and contribute to chronic headache. Therefore, clinicians should ask not only which medications patients take, but also how frequently they take them.
Distinguishing primary from secondary headaches requires combining the patient’s history, headache characteristics, associated symptoms, neurological examination, and risk factors. Tension-type headache, migraine, and cluster headache have recognizable clinical patterns and generally occur without persistent neurological abnormalities. Secondary headaches, however, should be considered whenever red flags or atypical features are present.
Using a systematic approach such as SNOOP can help clinicians identify patients who require urgent investigation while avoiding unnecessary testing in patients with typical primary headache disorders. Ultimately, safe headache management depends on recognizing the expected pattern—and recognizing when the presentation does not fit that pattern.
